article thumbnail

Dangerous data delays – a real-time problem

pharmaphorum

Delayed clinical trial data delivery is a growing problem for pharmaceutical companies and one that can have catastrophic consequences for the development of their promising pipeline candidates. But there are ways to improve this situation, as Remarque Systems’ recent Is a lack of real-time data holding trials back?

article thumbnail

Is a lack of real-time data holding trials back?

pharmaphorum

Their findings, published in the September 2018 research report Challenges and Opportunities in Clinical Data Management, underscore the severity of the problem. Delayed data delivery. Study data is typically collected by internal and external partners. Potentially catastrophic setbacks. That’s transformative.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bringing the Benefits of eCOA BYOD Strategies to Clinical Studies

pharmaphorum

Increased study adherence: Patients are most familiar with their own devices, and the ability to download an application and complete entries on a device they understand increases their adherence to the study requirements. Prior to joining IQVIA in 2018, J.C. With more than 20 years of industry experience, J.C.

article thumbnail

Methodology to Define a Pharma 4.0™ Roadmap

ISPE

Based on robust data flows, aspects and required controls can be assessed in detail—for example, manual data entry, interfaces between systems, media change, data conversion, data migration, and data archiving. Good Practices for Data Management and Integrity in Regulated GMP/GDP Environments.”